Chronic myeloid leukaemia trials in Australia

In Australia 10 Also abroad 171

10 trials · From ClinicalTrials.gov, checked 12 November 2026. Ask the study team whether a trial fits you.

Phase 2Taking people
Study to Determine the Efficacy and Safety of Asciminib in Pediatric Patients With Ph+ CML-CP
Where
Brisbane, North Adelaide
Age
1 year to 18 years
People
50 worldwide
Run by
Novartis Pharmaceuticals
See details and how to joinNCT07354074
Phase 1Enrolling by invitation
A Rollover Study for Continued Study Treatment and Ongoing Safety Monitoring
Where
Macquarie University, Melbourne, Nedlands, Randwick
Age
18 years and over
People
120 worldwide
Run by
Janssen Research & Development, LLC
See details and how to joinNCT06788509 · EU 2024-515457-21-00
Phase 1/2Taking people
A Clinical Study of MK-4208/TERN-701 in Participants With Chronic Myeloid Leukemia (CML) (MK-4208-003/Tern701-1012/CARDINAL)
Where
Adelaide, Clayton, Melbourne, Perth
Age
18 years to 64 years
People
330 worldwide
Run by
Terns, Inc., a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA)
See details and how to joinNCT06163430 · EU 2023-507677-18-00
Phase 2Taking people
(Apex) Bezuclastinib in Patients With Advanced Systemic Mastocytosis
Where
Kingswood, Melbourne N., Southport
Age
18 years and over
People
140 worldwide
Run by
Cogent Biosciences, Inc.
See details and how to joinNCT04996875 · EU 2024-511407-42-00
Phase 3Taking people
Study of Olverembatinib (HQP1351) in Patients With CML-CP
Where
Adelaide, Campbelltown, Liverpool, Perth
Age
18 years and over
People
333 worldwide
Run by
Ascentage Pharma Group Inc.
See details and how to joinNCT06423911 · EU 2024-511495-32-00
Phase 1/2Taking people
Study to Evaluate the Safety and Tolerability of EP0042
Where
Perth
Age
18 years and over
People
70 worldwide
Run by
Ellipses Pharma
See details and how to joinNCT04581512 · EU 2024-514588-24-00
Phase 1Taking people
A Phase 1a/1b Study of ELVN-001 for the Treatment Chronic Myeloid Leukemia
Where
Adelaide
Age
18 years and over
People
250 worldwide
Run by
Enliven Therapeutics
See details and how to joinNCT05304377 · EU 2023-503335-18-00
Phase 1Taking people
Combined Evaluation of Epigenetic and Sensitising Therapy in AML and MDS
Where
Sydney, Westmead
Age
18 years and over
People
12
Run by
Clinical Hub for Interventional Research (CHOIR)
See details and how to joinNCT05636514
Phase 1/2Taking people
Clinical Trial to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Tuspetinib (HM43239) in Patients With Relapsed or Refractory Acute Myeloid Leukemia
Where
Albury, Fitzroy, Herston, Nedlands, Townsville
Age
18 years and over
People
240 worldwide
Run by
Aptose Biosciences Inc.
See details and how to joinNCT03850574 · EU 2023-503244-14-00
No phaseTaking people
International Chronic Myeloid Leukemia Pediatric Study
Where
North Adelaide
Age
Up to 18 years
People
750 worldwide
Run by
Poitiers University Hospital
See details and how to joinNCT01281735